To elucidate the repertoire of biological phenomena that might be modulated by PRNP/PrPC in GBM, we analyzed bulk RNA sequencing (RNA-seq) data of patient-derived primary GBM samples (n=157) from The Cancer Genome Atlas (TCGA) database (Fig. 1A). This evidence concerns the gene PRNP and glioblastoma.